• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长激素分泌紊乱的病理生理学及其对骨小梁骨评分测量的骨微结构的影响。

Pathophysiology of growth hormone secretion disorders and their impact on bone microstructure as measured by trabecular bone score.

机构信息

5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, University Hospital Bratislava, Bratislava, Slovak Republic.

出版信息

Physiol Res. 2019 Nov 30;68(Suppl 2):S121-S129. doi: 10.33549/physiolres.934303.

DOI:10.33549/physiolres.934303
PMID:31842575
Abstract

This article is focused on endocrine-mediated osteoporosis caused by growth hormone (GH) disorders; adult GH deficiency and acromegaly. GH and insulin like growth factor-1 (IGF-1) stimulate linear bone growth through complex hormonal interactions and activates epiphyseal prechondrocytes. GH, via receptor activator of nuclear factor-kappaB (RANK), its ligand (RANK-L), and the osteoprotegerin system, stimulates production of osteoprotegerin and its accumulation in bone matrix. Malfunction of this mechanism, could lead to specific bone impairment. However, the primary problem of bone disease in GH secretion disorders is the primary prevention of osteoporotic fractures, so it is important to determine bone quality that better reflects the patient's actual predisposition to fracture. A method estimating bone quality from lumbar spine dual X-ray absorptiometry (DXA) scans is trabecular bone score (TBS). TBS in addition to bone mineral density (BMD) is a promising predictor of the osteoporotic fracture risk in women with postmenopausal osteopenia. In acromegaly TBS better defines risk of fracture because BMD is normal or even increased. TBS helps to monitor the effect of growth hormone therapy. Despite these findings, TBS should not be used alone, but a comprehensive consideration of all fracture risk factors, BMD and bone turnover markers is necessary.

摘要

本文重点介绍了由生长激素(GH)紊乱引起的内分泌介导性骨质疏松症;成人 GH 缺乏症和肢端肥大症。GH 和胰岛素样生长因子-1(IGF-1)通过复杂的激素相互作用刺激线性骨生长,并激活骺软骨前细胞。GH 通过核因子-κB 受体激活剂(RANK)、其配体(RANK-L)和骨保护素系统,刺激骨保护素的产生及其在骨基质中的积累。该机制的功能障碍可能导致特定的骨骼损伤。然而,GH 分泌紊乱导致的骨骼疾病的主要问题是预防骨质疏松性骨折,因此,确定更好地反映患者实际骨折易感性的骨骼质量非常重要。一种从腰椎双能 X 射线吸收法(DXA)扫描中估计骨骼质量的方法是小梁骨评分(TBS)。TBS 除了骨密度(BMD)之外,还是绝经后骨质疏松症女性骨质疏松性骨折风险的有前途的预测指标。在肢端肥大症中,TBS 更好地定义了骨折风险,因为 BMD 正常甚至增加。TBS 有助于监测生长激素治疗的效果。尽管有这些发现,但不应单独使用 TBS,而是需要综合考虑所有骨折风险因素、BMD 和骨转换标志物。

相似文献

1
Pathophysiology of growth hormone secretion disorders and their impact on bone microstructure as measured by trabecular bone score.生长激素分泌紊乱的病理生理学及其对骨小梁骨评分测量的骨微结构的影响。
Physiol Res. 2019 Nov 30;68(Suppl 2):S121-S129. doi: 10.33549/physiolres.934303.
2
Evaluation of trabecular bone score in patients with a distal radius fracture.桡骨远端骨折患者的小梁骨评分评估
Osteoporos Int. 2016 Dec;27(12):3559-3565. doi: 10.1007/s00198-016-3686-4. Epub 2016 Jun 24.
3
Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.地舒单抗对绝经后骨质疏松症女性的小梁骨评分的影响。
Osteoporos Int. 2017 Oct;28(10):2967-2973. doi: 10.1007/s00198-017-4140-y. Epub 2017 Jul 26.
4
Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.在临床实践中使用小梁骨评分(TBS)作为双能X线吸收法(DXA)的补充方法进行骨折风险评估。
J Clin Densitom. 2017 Jul-Sep;20(3):334-345. doi: 10.1016/j.jocd.2017.06.019. Epub 2017 Jul 19.
5
Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort.抗吸收治疗后小梁骨评分(TBS)的变化不能预测女性骨折:曼尼托巴骨密度队列研究
J Bone Miner Res. 2017 Mar;32(3):618-623. doi: 10.1002/jbmr.3054. Epub 2016 Dec 29.
6
Bone mineral density (BMD) and vertebral trabecular bone score (TBS) for the identification of elderly women at high risk for fracture: the SEMOF cohort study.骨密度(BMD)和椎体小梁骨评分(TBS)用于识别老年女性骨折高危人群:SEMOF队列研究
Eur Spine J. 2016 Nov;25(11):3432-3438. doi: 10.1007/s00586-015-4035-6. Epub 2015 May 27.
7
Comparisons of TBS and lumbar spine BMD in the associations with vertebral fractures according to the T-scores: A cross-sectional observation.根据 T 评分,比较 TBS 和腰椎骨密度与椎体骨折的相关性:一项横断面观察。
Bone. 2017 Dec;105:269-275. doi: 10.1016/j.bone.2017.09.017. Epub 2017 Sep 28.
8
The Long-Term Effects of Growth Hormone Replacement on Bone Mineral Density and Trabecular Bone Score: Results of the 10-Year Prospective Follow-up.生长激素替代治疗对骨密度和骨小梁评分的长期影响:10 年前瞻性随访结果。
Physiol Res. 2021 Nov 30;70(Suppl 1):S61-S68. doi: 10.33549/physiolres.934775.
9
Trabecular bone score (TBS) is associated with sub-clinical vertebral fractures in HIV-infected patients.小梁骨评分(TBS)与HIV感染患者的亚临床椎体骨折相关。
J Bone Miner Metab. 2018 Jan;36(1):111-118. doi: 10.1007/s00774-017-0819-6. Epub 2017 Feb 23.
10
The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.骨小梁骨评分与终末期肾病患者的骨密度、骨转换标志物和骨折患病率相关。
Osteoporos Int. 2018 Jun;29(6):1447-1455. doi: 10.1007/s00198-018-4468-y. Epub 2018 Mar 19.

引用本文的文献

1
Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study.50岁及以上全垂体功能减退患者的骨折风险:一项全国性队列研究。
Osteoporos Int. 2025 Jul 8. doi: 10.1007/s00198-025-07574-2.
2
Skeletal fragility in pituitary disease: how can we predict fracture risk?垂体疾病中的骨骼脆性:我们如何预测骨折风险?
Pituitary. 2024 Dec;27(6):789-801. doi: 10.1007/s11102-024-01447-3. Epub 2024 Sep 6.
3
The influence of growth hormone deficiency on bone health and metabolisms.生长激素缺乏对骨骼健康和代谢的影响。
Reumatologia. 2023;61(4):239-247. doi: 10.5114/reum/170244. Epub 2023 Aug 31.
4
Chromosome-level Asian elephant genome assembly and comparative genomics of long-lived mammals reveal the common substitutions for cancer resistance.亚洲象染色体水平基因组组装及长寿命哺乳动物比较基因组揭示了癌症抗性的常见替代。
Aging Cell. 2023 Sep;22(9):e13917. doi: 10.1111/acel.13917. Epub 2023 Jul 3.
5
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience.肢端肥大症诊断延迟对骨骼健康的影响:来自真实生活和长期随访经验的数据。
Pituitary. 2022 Dec;25(6):831-841. doi: 10.1007/s11102-022-01266-4. Epub 2022 Aug 3.
6
The Long-Term Effects of Growth Hormone Replacement on Bone Mineral Density and Trabecular Bone Score: Results of the 10-Year Prospective Follow-up.生长激素替代治疗对骨密度和骨小梁评分的长期影响:10 年前瞻性随访结果。
Physiol Res. 2021 Nov 30;70(Suppl 1):S61-S68. doi: 10.33549/physiolres.934775.
7
Introduction to DOK2 and its potential role in cancer.DOK2 简介及其在癌症中的潜在作用。
Physiol Res. 2021 Nov 29;70(5):671-685. doi: 10.33549/physiolres.934710. Epub 2021 Sep 10.
8
DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis.在激素介导的继发性骨质疏松症的骨折风险预测中,DXA 参数、骨小梁评分(TBS)和骨密度(BMD)。
Endocrine. 2021 Oct;74(1):20-28. doi: 10.1007/s12020-021-02806-x. Epub 2021 Jul 10.
9
The intriguing giant deer from the Bate cave (Crete): could paleohistological evidence question its taxonomy and nomenclature?来自贝特洞穴(克里特岛)的迷人巨型鹿:古组织学证据能否质疑其分类学和命名法?
Integr Zool. 2022 Jan;17(1):54-77. doi: 10.1111/1749-4877.12533. Epub 2021 Apr 6.
10
Update on vertebral fractures in pituitary diseases: from research to clinical practice.垂体疾病相关椎体骨折的最新研究进展:从基础到临床。
Hormones (Athens). 2021 Sep;20(3):423-437. doi: 10.1007/s42000-021-00275-5. Epub 2021 Feb 19.